Aemetis Biogas Receives Proceeds from Sale of $7.7 Million of Investment Tax Credits
CUPERTINO, CA - February 26, 2025 ( NEWMEDIAWIRE) - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company, announced today the receipt of $6 million of cash, after transaction costs, from the sale of $7.7 million of Inflation Reduction Act (IRA) investment tax credits generated by the construction of dairy biogas digesters by the Aemetis Biogas subsidiary of the company. The investment tax credits were sold to a corporate purchaser that had previously agreed to purchase the tax credits as a part of a multi-closing purchase arrangement.
The IRA was signed into law in August 2022 and provides transferable federal income tax credits for investments in certain renewable fuel projects, as well as production tax credits for low carbon intensity renewable fuels. Aemetis generated IRA Section 48 investment tax credits from its investment in dairy biogas digesters constructed and placed in service by Aemetis in Q4 2024.
'The $6 million of net cash proceeds received by Aemetis yesterday is in addition to $11 million of cash proceeds from tax credits sold last month, funding domestic energy production projects and reducing dependence on imported crude oil,' stated Eric McAfee, Chairman and CEO of Aemetis. 'The next sales of investment tax credits will be generated by biogas digester and pipeline projects that are currently under construction and expected to be completed in Q2 2025.'
The Aemetis Keyes ethanol plant supplies about two million pounds of animal feed daily to feed more than 100,000 dairy cows at about 80 dairies in the local area. To capture methane at dairies and produce renewable natural gas (RNG), Aemetis is operating twelve dairy digesters, 36 miles of biogas pipeline, a central biogas to RNG production facility, and a PG&E utility gas pipeline interconnection. Aemetis expects to produce 550,000 MMBtu of RNG per year from its existing projects combined with those planned for completion in Q2.
Approximately 25% of methane emissions in California are emitted by dairy waste lagoons that do not have methane capture systems such as those installed by Aemetis. When fully built, the Aemetis Biogas project plans to capture methane from the waste produced by more than 150,000 cows at dairy farms in California and produce 1,650,000 MMBtu of renewable natural gas from captured dairy methane each year. When fully operational, the Aemetis Biogas project in California is designed to reduce greenhouse gas emissions equivalent to an estimated 6.8 million metric tons of carbon dioxide over ten years.
About Aemetis
Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and biochemicals company focused on the operation, acquisition, development, and commercialization of innovative technologies that replace petroleum-based products and reduce greenhouse gas emissions. Founded in 2006, Aemetis is operating and actively expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California's Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates an 80 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis acquired the 125-acre former Army Ammunition Production Plant site in Riverbank, California to develop a carbon sequestration project and a sustainable aviation fuel (SAF) and renewable diesel fuel biorefinery to utilize renewable hydrogen, hydroelectric power, and renewable oils to produce low carbon intensity renewable jet and diesel fuel. For additional information about Aemetis, please visit www.aemetis.com.
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements include, without limitation, projections of financial results in 2025 and future years; statements relating to the development, engineering, financing, construction and operation of the Aemetis ethanol, biogas, biodiesel, SAF and renewable diesel, and carbon sequestration facilities; and our ability to promote, develop, finance, and deploy technologies to produce renewable fuels and biochemicals. Words or phrases such as 'anticipates,' 'may,' 'will,' 'should,' 'believes,' 'estimates,' 'expects,' 'intends,' 'plans,' 'predicts,' 'projects,' 'showing signs,' 'targets,' 'view,' 'will likely result,' 'will continue' or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Reports on Form 10-K, and in our other filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
External Investor Relations
Contact:
PCG Advisory Group
(646) 863-6519
Company Investor Relations/
Media Contact:
Todd Waltz
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
If I Could Only Buy and Hold a Single Stock, This Would Be It
Key Points Amazon and its management team are experienced with trying new things. Every success or failure, however, is a learning experience. History has shown that companies that foster innovation and don't punish failure tend to thrive, while those that fear it or are unwilling to adapt often struggle. 10 stocks we like better than Amazon › Investors can own as many individual stocks as they want and can afford. Sometimes, though, hypothetically imagining that you're limited to just one can be enlightening. That thought experiment forces you to rate and rank the strengths and flaws of every investment candidate on your radar. This process can -- in a good way -- really help you narrow down your list to a small handful of top options. Or one. And I know exactly which one that would be for me. If I could only buy and hold a single stock, it would be Amazon (NASDAQ: AMZN). Here's why. What Amazon really is You very likely already know the company. Amazon is, of course, the king of North American e-commerce, accounting for nearly 40% of the market's total revenue, according to research by Digital Commerce 360. It's doing alright overseas, too. Then there's its cloud computing arm, Amazon Web Services, which provides a relatively small portion of its revenue, but is responsible for nearly 60% of the company's operating profits. However, these numbers still don't even come close to telling the whole story. Amazon also manages an on-demand video platform (Prime), owns grocery store chain Whole Foods Markets, does delivery work for other online retailers, and sells prescription pharmaceuticals through its Pillpack arm. It also monetizes its online mall by allowing its sellers to pay for more prominent promotion, creating an advertising business that generated $15.7 billion in revenue last quarter alone, by the way. On top of all that, it owns websites and Twitch, and is the parent to camera-doorbell brand Ring. There's a method to the madness behind these seemingly disparate lines of business, though. While most companies focus on doing one or two things extremely well, Amazon has orchestrated several different lines of business, each of which fuels another, and each of which is fueled by another. The result is a mesh of different profit centers that ultimately funnels consumers and corporations into Amazon's ecosystem. Yes, it's complicated, but yes, Amazon can handle it. That's not quite the only reason I'd be willing to make Amazon my one and only stock holding, though. Jeff Bezos started it Companies founded or grown by bigger-than-life leaders can make for potentially problematic investments. It's just difficult to determine if it's the company that's something special, or the person. If it's the person, what happens when that individual is no longer at the helm? Case in point: General Electric was never quite the same after Jack Welch stepped down as CEO in 2001. Steve Jobs was also nearly synonymous with Apple until he passed the torch to Tim Cook in 2011. While Cook has been a solid successor, he's arguably not quite as captivating or magical as his predecessor. Neither is Apple under him. Still, most high-profile chief executives -- and founders in particular -- manage to leave their mark on their company's culture. That imprint remains part of the organization's ethos even in their absence. While current Amazon CEO Andy Jassy is no Jeff Bezos, for instance, Bezos' philosophy remains. Take, for example, the company's willingness to experiment. As Bezos noted in his 2016 letter to Amazon's shareholders, "Most large organizations embrace the idea of invention, but are not willing to suffer the string of failed experiments necessary to get there." That does not describe Amazon, though. Bezos made a point of fostering a "fail fast, fail often" work culture that did end up producing some failures, such as the Fire smartphone. Such experiments, however, also led to the creation of Amazon Web Services and Amazon Prime, the latter of which has been a massive growth driver for the company. Now Jassy is blending his own mindset with Bezos'. As he said while discussing the company's core 16 leadership principles, "At Amazon, you are not just empowered to speak up if you think we're doing something wrong for customers of the business. You're expected to do so, regardless of level." It works. Amazon is an even bigger company now than it was when Bezos stepped down as CEO. Don't underestimate the power of a willingness to innovate Many investors will point out that a healthy corporate culture doesn't pay the bills. I agree. At some point, to thrive, every company must sell its products or services profitably. Amazon is no exception. History has shown, however, that companies with corporate cultures that encourage innovation and don't punish failure tend to prosper while organizations that are cautiously and defensively managed often struggle. Compare Alphabet today to post-Welch GE, for instance. The manufacturing conglomerate ultimately hit a wall after years of obscuring the true depth of its insurance arm's liabilities from a management team that might have been able to fix them (although the company didn't exactly embrace the advent of the digital age either). Or compare Blockbuster to Netflix. The once-giant video rental chain infamously had a chance to buy the latter for a mere $50 million back in 2000. At the time, Blockbuster was doing on the order of $4 billion worth of business per year, and could have easily purchased Netflix, if only to take its budding competitor out of the market. But it didn't. In its defense, Blockbuster's decision at the time wasn't quite the obvious misstep it seems in retrospect. Remember, Netflix wasn't yet streaming then. It was still only renting DVDs by mail. Given Blockbuster's dominance of the brick-and-mortar movie rental business back in 2000, the logistics behind this new kind of movie rental business model understandably didn't make sense to the now-defunct company. In many regards, though, that story underscores the underlying theme here in an even more effective way. Even if Blockbuster didn't want Netflix, Blockbuster certainly could have leveraged its own powerful brand to become a streaming powerhouse. Likewise, if not Netflix, some other enterprising outfit would have eventually launched the streaming-video business. Netflix was simply the outfit that tried the idea out first, knowing when it did so that it might end in failure. So for my money, I'll bet on a company that is experienced with managing experiments' successes as well as failures -- and learning from both -- to evolve and thrive. That said, it certainly doesn't hurt the bullish argument that Amazon has the financial flexibility to experiment. With its $2.5 trillion market cap, it does more than $600 billion worth of business per year, and turns about $60 billion of that into net income. Meanwhile, it's only sitting on a little over $80 billion in long-term debt. It's much easier not to fear failure when you can actually afford to take big swings, miss, and try again. Should you invest $1,000 in Amazon right now? Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 James Brumley has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, and Netflix. The Motley Fool recommends GE Aerospace. The Motley Fool has a disclosure policy. If I Could Only Buy and Hold a Single Stock, This Would Be It was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
GoodRx Is Soaring on a Novo Nordisk Deal. Should You Buy GDRX Stock Here?
GoodRx (GDRX) shares soared nearly 50% on Monday after announcing a GLP-1 partnership with the Danish pharmaceutical behemoth Novo Nordisk (NVO). In a press release this morning, the Nasdaq-listed firm said 'all strengths of Ozempic and Wegovy pens are now available to eligible self-paying patients for $499-per-month through GoodRx.' More News from Barchart Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Lyft Generates Huge FCF Margins - LYFT Stock Is Too Cheap Cathie Wood Is Buying BLSH Stock After the Bullish IPO. Should You? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! GoodRx stock has slightly outperformed in 2025, up just over 12% in the year to date. How Novo Deal May Help GoodRx Stock Teaming up with Novo Nordisk is a major win for GDRX shares because it positions the healthcare platform at the center of the booming GLP-1 weight-loss and diabetes drug market. Offering Ozempic and Wegovy at a flat $499 per month to self-paying customers helps GoodRx expand access to high-demand medications while reinforcing its value proposition as a cost-saving platform. Over time, this could drive user growth, boost engagement, and attract new pharmacy and pharma partnerships as well. In short, with GLP-1 drugs making headlines and consumer interest soaring, GoodRx stock is now tied to one of the most lucrative trends in healthcare. Why BofA Remains Bearish on GDRX Shares Despite the aforementioned positives, Bank of America analyst Allen Lutz says the Novo Nordisk deal is far from a sufficient reason to load up on GoodRx shares at current levels. In a note to clients, Lutz argued widespread pharmacy closures and changing reimbursement policy could make it difficult for GDRX stock to retain momentum in the days ahead. On Monday, the BofA analyst maintained his 'Underperform' rating and $3.40 price target on the healthcare platform, indicating potential downside of more than 30% from here. Wall Street Disagrees with BofA on GoodRx Investors should note, however, that Bank of America Securities is among the more bearish Wall Street firms on GoodRx stock in 2025. According to Barchart, the consensus rating on GDRX shares remains at 'Moderate Buy' with the mean target of $5.49 indicating potential 'upside' of another 5% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
City takes bold strides in major lawsuit against leading oil companies: 'Very significant'
City takes bold strides in major lawsuit against leading oil companies: 'Very significant' Honolulu is making waves, but this time, it's in court. The Associated Press reported (via Daily Breeze) that the city and county are moving ahead with a lawsuit against some of the world's biggest oil companies, including Chevron, ExxonMobil, and Shell. Though a trial is still a long way off, the case is more advanced than 30 similar nationwide lawsuits and could set the tone for how courts hold polluters accountable. The suit claims that the oil companies misled the public about the risks of dirty energy sources. Since these are widely used across the world, they have contributed to rising sea levels and more extreme weather. The city argues that pollution created largely through the burning of dirty energy sources such as oil and gas has burdened taxpayers and local infrastructure. Hawai'i has experienced firsthand the effects of the warming planet. Human-caused pollution overheats Earth, melts glaciers, and expands ocean water. According to the Hawaiian government, coastal erosion is forcing residents to retreat inland, while severe flooding is putting pressure on emergency response systems and aging infrastructure. While the challenge is great, there's movement in the right direction. This legal action seeks damages, which could fund climate adaptation efforts, such as upgraded infrastructure and protections for vulnerable communities. This legal strategy is gaining traction. Other cities across the United States have filed similar suits. National policies including the Inflation Reduction Act and local climate resilience plans are helping cities transition away from dirty energy while preparing for the effects of extreme weather. While the legal battle is far from over, Honolulu's case marks a step in the global effort to hold major polluters accountable. Michael Gerrard, the founder and faculty director of the Columbia University Sabin Center for Climate Change Law, identified the lawsuit as pivotal. "The first trial in any of these cases will be very significant," said Gerrard, per the AP. "It will get a large amount of nationwide or even global attention because the oil companies have not yet had to take the stand and defend themselves in a trial." Do you think America does a good job of protecting its natural beauty? Definitely Only in some areas No way I'm not sure Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
